Work-Related Symptoms of Patients with Asthma: A Multicenter Study

Mungan, Dilşad; Özmen, İpek; Evyapan, Fatma; Topçu, Füsun; Akgün, Metin; Arbak, Peri; Bülbül, Yılmaz

doi:10.5152/turkthoracj.2018.18123

Cited by 1 publication

(3 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Meanwhile, Tiotiu, et al (2020) found that adults with asthma with full-time occupations who were younger and more often had non-manual occupations, experienced fewer asthma symptoms, used fewer asthma medications, and smoked less than subjects with occupation disabilities. 17 Moreover, Mungan, et al (2019) showed that asthma patients had significant exposures to occupations that worsened their symptoms. 18 Hence, asthmatics and clinicians need to be educated about the prevalence and risks of exposure in the workplace (as well as at home) to minimize asthma triggers and exacerbations.…”

Section: Discussionmentioning

confidence: 99%

“…17 Moreover, Mungan, et al (2019) showed that asthma patients had significant exposures to occupations that worsened their symptoms. 18 Hence, asthmatics and clinicians need to be educated about the prevalence and risks of exposure in the workplace (as well as at home) to minimize asthma triggers and exacerbations. 18 Stolbrink, et al (2022) showed no difference in adherence between patients, indicating that prescription costs did not impact adherence to maintenance therapy for asthma or chronic obstructive pulmonary disease (COPD).…”

Section: Discussionmentioning

confidence: 99%

“…18 Hence, asthmatics and clinicians need to be educated about the prevalence and risks of exposure in the workplace (as well as at home) to minimize asthma triggers and exacerbations. 18 Stolbrink, et al (2022) showed no difference in adherence between patients, indicating that prescription costs did not impact adherence to maintenance therapy for asthma or chronic obstructive pulmonary disease (COPD). 19 According to Chen, et al (2020), COPD costs were strongly correlated with disease severity, hospitalization was the primary contributor to medical costs, and non-adherence to maintenance treatment negatively correlated with resource utilization and health care costs.…”

Section: Discussionmentioning

confidence: 99%

See 2 more Smart Citations

Asthma Exacerbation during the COVID-19 Pandemic

Sawitri,

Roosihermiatie,

Adji

et al. 2023

View full text Add to dashboard Cite

Introduction: Asthmatics, especially uncontrolled asthmatics, must be vigilant during the COVID-19 pandemic to avoid major respiratory complications. This study aimed to describe these characteristics in emergency unit patients with asthma and COVID-19 at Haji General Hospital, Surabaya, an East Java referral hospital. Methods: The study gathered medical information on 160 asthma patients from March to December 2021. The collected data were related to socioeconomics, allergy history, family allergy history, and medications. Results: 160 confirmed cases of asthma occurred during COVID-19 at Haji General Hospital, Surabaya. Most adult asthma sufferers were women (59.2%), high school graduates (31.25%), housewives (21.2%), had payment method with Social Health Insurance Administration Body (BPJS) insurance (73.8 %), had a history of drug allergies (11.5%), had no family history of allergies (50.8%), and used albuterol control drugs (10.7%). Meanwhile, the majority of children with asthma were boys (53.3%), did not attend school or did not finish elementary school (33.3%), did not work (33.3%), had payment method with BPJS (73.3%), had a history of allergies to seafood and cow's milk respectively (10%), had no family history of allergies (40%), and used albuterol control drugs (16.7%). Conclusion: The proportion of asthma in the emergency unit was dominated by women over 18 years old with a high school education. Most patients were housewives and used BPJS. Many of them had a history of allergies to medications (not asthma medication), and there was no family history of allergies. Commonly used medications were albuterol to control asthma.

show abstract